HRTS ETF
Tema Heart & Health ETF
LLY is HRTS's largest holding at 11.51% of the fund as of Oct 1, 2026. HRTS is Tema Heart & Health ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | L | Eli Lilly & Co.Health Care · Pharmaceuticals | 11.51% | 11.5% | 5,308 | $6.10M | Health Care | Pharmaceuticals |
| 2 | T | Thermo Fisherscientific Inc.Health Care · Life Sciences Tools | 5.64% | 17.1% | 4,586 | $2.99M | Health Care | Life Sciences Tools |
| Sector and industry · Pro | ||||||||
| 3 | U | Unitedhealth Group Inc | 4.67% | 21.8% | 6,779 | $2.48M | ||
| 4 | M | Merck & Company Inc | 4.37% | 26.2% | 16,125 | $2.32M | ||
| 5 | — | Novo Nordisk As | 4.13% | 30.3% | 58,231 | $2.19M | ||
| 6 | R | Revolution Medicines Inc Ser C Pc Pp | 3.84% | 34.2% | 9,885 | $2.04M | ||
| 7 | R | Roche Holding Ag (Adr) | 3.82% | 38.0% | 38,717 | $2.03M | ||
| 8 | J | Johnson & Johnson - | 3.63% | 41.6% | 7,434 | $1.92M | ||
| 9 | C | Cytokinetics Inc | 3.40% | 45.0% | 27,464 | $1.80M | ||
| 10 | G | Gilead Sciences | 3.28% | 48.3% | 11,805 | $1.74M | ||
| 11 | B | Bridgebio Pharma Inc_None_0 | 3.13% | 51.4% | 24,840 | $1.66M | ||
| 12 | D | Danaher Corp | 3.08% | 54.5% | 7,704 | $1.63M | ||
| 13 | — | AstraZeneca PLC | 2.96% | 57.5% | 9,903 | $1.57M | ||
| 14 | — | Nvaesrtex Pharmaceuticals Inc | 2.92% | 60.4% | 3,059 | $1.55M | ||
| 15 | — | Abbot Laboratories | 2.82% | 63.2% | 15,497 | $1.50M | ||
| 16 | N | Novartis Ag - | 2.71% | 65.9% | 10,132 | $1.44M | ||
| 17 | A | AbbVie Inc. | 2.48% | 68.4% | 5,054 | $1.31M | ||
| 18 | I | Intuitive Surgical Inc. | 2.40% | 70.8% | 3,179 | $1.28M | ||
| 19 | K | Kodiak Sciences Inc | 2.33% | 73.1% | 12,572 | $1.24M | ||
| 20 | B | Bristol-Myers Squibb Co. | 2.15% | 75.3% | 18,594 | $1.14M | ||
| 21 | M | Medtronic Plc Ordinary Shares | 2.11% | 77.4% | 12,942 | $1.12M | ||
| 22 | M | Mckesson Corp. | 1.99% | 79.4% | 1,175 | $1.06M | ||
| 23 | D | Dexcom Inc. | 1.54% | 80.9% | 9,478 | $817.3K | ||
| 24 | M | Madrigal Pharmaceuticals Inc | 1.40% | 82.3% | 1,489 | $744.1K | ||
| 25 | S | Stryker Corp | 1.40% | 83.7% | 2,715 | $741.1K | ||
| 26 | E | Edwards Lifesciences Corp | 1.37% | 85.1% | 8,515 | $725.4K | ||
| 27 | — | Otsuka Holdings Co., Ltd. Com Stk | 1.25% | 86.3% | 9,152 | $663.6K | ||
| 28 | B | Boston Scientific Corp. | 1.23% | 87.6% | 15,112 | $653.3K | ||
| 29 | — | Teva Pharmaceutical Industries Limited (Adr) | 1.22% | 88.8% | 16,443 | $646.4K | ||
| 30 | A | Alnylam Pharmaceuticals Inc. | 1.11% | 89.9% | 2,549 | $589.3K | ||
| 31 | I | Illumina, Inc. | 1.11% | 91.0% | 2,208 | $586.7K | ||
| 32 | R | Regeneron Pharmaceuticals, Inc. | 1.04% | 92.0% | 754 | $554.0K | ||
| 33 | — | Chugai Pharmaceutical Co. Ltd. Com Stk | 1.00% | 93.0% | 13,639 | $532.6K | ||
| 34 | C | Centene | 0.94% | 94.0% | 8,197 | $499.9K | ||
| 35 | A | Amgen Inc. | 0.81% | 94.8% | 1,055 | $429.7K | ||
| 36 | F | First Am Treas Obli-X | 0.69% | 95.5% | 367,155 | $367.2K | ||
| 37 | A | Arrowhead Pharmaceuticals Inc | 0.64% | 96.1% | 5,228 | $338.7K | ||
| 38 | X | Xenon Pharmaceuticals Inc. Common Shares | 0.60% | 96.7% | 8,228 | $320.3K | ||
| 39 | M | Mbx Biosciences Inc | 0.53% | 97.3% | 4,977 | $281.4K | ||
| 40 | S | Scholar Rock Holding Corp | 0.53% | 97.8% | 6,136 | $283.2K | ||
| 41 | S | Stoke Therapeutics Inc | 0.48% | 98.3% | 9,851 | $256.2K | ||
| 42 | V | Viking Therapeutics Inc | 0.48% | 98.7% | 8,370 | $255.4K | ||
| 43 | P | Insulet Corp | 0.45% | 99.2% | 1,815 | $237.4K | ||
| 44 | I | Insmed Inc | 0.41% | 99.6% | 2,025 | $219.9K | ||
| 45 | Z | Zealand Pharma A/s | 0.37% | 100.0% | 5,188 | $198.6K | ||
| 46 | — | British Pounds | 0.30% | 100.3% | 122,119 | $-161147 | ||
| 47 | K | Kailera Therapeutics Inc | 0.29% | 100.6% | 13,945 | $153.8K | ||
| 48 | — | Us Dollar | 0.00% | 100.6% | 1,260 | $1.3K | ||
HRTS ETF All Holdings
HRTS holdings total 92 positions. The top 10 holdings account for 48.3% of the fund, led by Eli Lilly & Co. at 11.5%, Thermo Fisherscientific Inc. at 5.6%, Unitedhealth Group Incorporated at 4.7%.
HRTS portfolio concentration is moderate, with the top 10 representing 48.3% of total assets. The largest sector exposure is Health Care at 83.0%.
HRTS sectors provide a detailed breakdown. HRTS overlap shows how holdings compare to other funds in your portfolio.
HRTS ETF Holdings
48 of 92 holdings
- 1
Eli Lilly & Co.
LLYHealth Care11.51% - 2
Thermo Fisherscientific Inc.
TMOHealth Care5.64% - 3
Unitedhealth Group Incorporated
UNHHealth Care4.67% - 4
Merck & Company Inc
MRKHealth Care4.37% - 5
Novo Nordisk As
NOVO.B:COUnknown4.13% - 6
Revolution Medicines Inc Ser C Pc Pp
RVMDHealth Care3.84% - 7
Roche Holding Ag (Adr)
RHHBY:SMUnknown3.82% - 8
Johnson & Johnson - Common
JNJHealth Care3.63% - 9
Cytokinetics Inc
CYTKHealth Care3.40% - 10
Gilead Sciences
GILDHealth Care3.28% - 11
Bridgebio Pharma Inc_None_0
BBIOHealth Care3.13% - 12
Danaher Corporation
DHRHealth Care3.08% - 13
AstraZeneca PLC
AZN:LNUnknown2.96% - 14
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care2.92% - 15
Abbot Laboratories
ABTHealth Care2.82% - 16
Novartis Ag - Common
NOVN:SMUnknown2.71% - 17
Abbvie Inc.
ABBVHealth Care2.48% - 18
Intuitive Surgical Inc.
ISRGHealth Care2.40% - 19
Kodiak Sciences Inc
KODHealth Care2.33% - 20
Bristol-Myers Squibb Co.
BMYHealth Care2.15% - 21
Medtronic Plc Ordinary Shares
MDTHealth Care2.11% - 22
Mckesson Corp.
MCKHealth Care1.99% - 23
Dexcom Inc.
DXCMHealth Care1.54% - 24
Madrigal Pharmaceuticals Inc
MDGLHealth Care1.40% - 25
Stryker Corp
SYKHealth Care1.40% - 26
Edwards Lifesciences Corp
EWHealth Care1.37% - 27
Otsuka Holdings Co., Ltd. Com Stk
4578:JPUnknown1.25% - 28
Boston Scientific Corp.
BSXHealth Care1.23% - 29
Teva Pharmaceutical Industries Limited (Adr)
TEVA:ILHealth Care1.22% - 30
Alnylam Pharmaceuticals Inc.
ALNYHealth Care1.11% - 31
Illumina, Inc.
ILMNHealth Care1.11% - 32
Regeneron Pharmaceuticals, Inc.
REGNHealth Care1.04% - 33
Chugai Pharmaceutical Co. Ltd. Com Stk
4519:JPUnknown1.00% - 34
Centene
CNCHealth Care0.94% - 35
Amgen Inc.
AMGNHealth Care0.81% - 36
First Am Treas Obli-X
FXFXXFinancials0.69% - 37
Arrowhead Pharmaceuticals Inc
ARWRHealth Care0.64% - 38
Xenon Pharmaceuticals Inc. Common Shares
XENEHealth Care0.60% - 39
Mbx Biosciences Inc
MBXHealth Care0.53% - 40
Scholar Rock Holding Corporation Com
SRRKHealth Care0.53% - 41
Stoke Therapeutics Inc Com
STOKHealth Care0.48% - 42
Viking Therapeutics Inc Com
VKTXHealth Care0.48% - 43
Insulet Corporation
PODDHealth Care0.45% - 44
Insmed Inc
INSMHealth Care0.41% - 45
Zealand Pharma A/s
ZEAL:COUnknown0.37% - 46
British Pounds
Other0.30% - 47
Kailera Therapeutics Inc
KLRAUnknown0.29% - 48
Us Dollar
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | LLY | 11.510% | ||
| 2 | Thermo Fisherscientific Inc. | TMO | 5.640% | ||
| 3 | Unitedhealth Group Incorporated | UNH | 4.670% | ||
| 4 | Merck & Company Inc | MRK | 4.370% | ||
| 5 | Novo Nordisk As | NOVO.B:CO | 4.130% | ||
| 6 | Revolution Medicines Inc Ser C Pc Pp | RVMD | 3.840% | ||
| 7 | Roche Holding Ag (Adr) | RHHBY:SM | 3.820% | ||
| 8 | Johnson & Johnson - Common | JNJ | 3.630% | ||
| 9 | Cytokinetics Inc | CYTK | 3.400% | ||
| 10 | Gilead Sciences | GILD | 3.280% | ||
| 11 | Bridgebio Pharma Inc_None_0 | BBIO | 3.130% | ||
| 12 | Danaher Corporation | DHR | 3.080% | ||
| 13 | AstraZeneca PLC | AZN:LN | 2.960% | ||
| 14 | Nvaesrtex Pharmaceuticals Inc | VRTX | 2.920% | ||
| 15 | Abbot Laboratories | ABT | 2.820% | ||
| 16 | Novartis Ag - Common | NOVN:SM | 2.710% | ||
| 17 | Abbvie Inc. | ABBV | 2.480% | ||
| 18 | Intuitive Surgical Inc. | ISRG | 2.400% | ||
| 19 | Kodiak Sciences Inc | KOD | 2.330% | ||
| 20 | Bristol-Myers Squibb Co. | BMY | 2.150% | ||
| 21 | Medtronic Plc Ordinary Shares | MDT | 2.110% | ||
| 22 | Mckesson Corp. | MCK | 1.990% | ||
| 23 | Dexcom Inc. | DXCM | 1.540% | ||
| 24 | Madrigal Pharmaceuticals Inc | MDGL | 1.400% | ||
| 25 | Stryker Corp | SYK | 1.400% | ||
| 26 | Edwards Lifesciences Corp | EW | 1.370% | ||
| 27 | Otsuka Holdings Co., Ltd. Com Stk | 4578:JP | 1.250% | ||
| 28 | Boston Scientific Corp. | BSX | 1.230% | ||
| 29 | Teva Pharmaceutical Industries Limited (Adr) | TEVA:IL | 1.220% | ||
| 30 | Alnylam Pharmaceuticals Inc. | ALNY | 1.110% | ||
| 31 | Illumina, Inc. | ILMN | 1.110% | ||
| 32 | Regeneron Pharmaceuticals, Inc. | REGN | 1.040% | ||
| 33 | Chugai Pharmaceutical Co. Ltd. Com Stk | 4519:JP | 1.000% | ||
| 34 | Centene | CNC | 0.940% | ||
| 35 | Amgen Inc. | AMGN | 0.810% | ||
| 36 | First Am Treas Obli-X | FXFXX | 0.690% | ||
| 37 | Arrowhead Pharmaceuticals Inc | ARWR | 0.640% | ||
| 38 | Xenon Pharmaceuticals Inc. Common Shares | XENE | 0.600% | ||
| 39 | Mbx Biosciences Inc | MBX | 0.530% | ||
| 40 | Scholar Rock Holding Corporation Com | SRRK | 0.530% | ||
| 41 | Stoke Therapeutics Inc Com | STOK | 0.480% | ||
| 42 | Viking Therapeutics Inc Com | VKTX | 0.480% | ||
| 43 | Insulet Corporation | PODD | 0.450% | ||
| 44 | Insmed Inc | INSM | 0.410% | ||
| 45 | Zealand Pharma A/s | ZEAL:CO | 0.370% | ||
| 46 | British Pounds | - | 0.300% | ||
| 47 | Kailera Therapeutics Inc | KLRA | 0.290% | ||
| 48 | Us Dollar | - | 0.000% |






































